外周动脉疾病 (PAD)的临床试验
总计14800个结果
-
Eli Lilly and CompanyDaiichi Sankyo Co., Ltd.终止
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Changhai Hospital招聘中
-
Biotronik AG主动,不招人
-
University Hospital, Angers完全的
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)完全的
-
University of MinnesotaNational Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS)完全的
-
University of PernambucoFundação de Amparo à Pesquisa do Estado de São Paulo完全的
-
University Hospital, AngersRégion des Pays de la Loire完全的
-
Ettore Sansavini Health Science Foundation完全的
-
Biotronik AG完全的动脉硬化 | 动脉粥样硬化 | 外周动脉疾病 | 血管疾病比利时, 奥地利, 德国
-
National Heart, Lung, and Blood Institute (NHLBI)完全的
-
GE HealthcarePharmaceutical Product Development, LLC完全的
-
B. Braun Melsungen AGCharite University, Berlin, Germany完全的
-
National Heart, Lung, and Blood Institute (NHLBI)完全的
-
Ettore Sansavini Health Science Foundation终止
-
Astellas Pharma Global Development, Inc.完全的使用单光子发射计算机断层扫描 (SPECT) 进行心肌灌注成像 (MPI) 与单独使用 Regadenoson 相比,在不充分的运动压力测试后评估 Regadenoson 给药的研究 (EXERRT)冠状动脉疾病 (CAD)美国, 秘鲁, 阿根廷, 波多黎各
-
Palo Alto Veterans Institute for ResearchW.L.Gore & Associates; Boston Scientific Corporation; Abbott; Cook Group Incorporated招聘中
-
Zhejiang Genfleet Therapeutics Co., Ltd.撤销
-
University of OklahomaNational Institute on Aging (NIA); Case Western Reserve University尚未招聘
-
Yonsei University未知伴有股腘病变的症状性外周动脉疾病 | 中度或重度跛行(Rutherford 类别 2 或 3) | 严重肢体缺血(卢瑟福 4 或 5 类)大韩民国
-
Ottawa Heart Institute Research CorporationHeart and Stroke Foundation of Ontario完全的
-
Imperial College LondonImperial College Healthcare NHS Trust招聘中
-
C. R. Bard完全的